Votre événement devrait être ici ! Pour référencer, gérer, promouvoir... Pour s'informer ou se former ... Inscriptions en ligne

Langue du site : Français - English
Réf : 30613
Evènement :SMi's 4th Annual 3D Cell Culture Conference

Dates :Mardi 18 Février 2020 - Jeudi 20 Février 2020

Lieu :Copthorne Tara Hotel London Kensington
Scarsdale Place
W8 5SY London, Royaume-Uni

Type :Conférence & Séminaire - Audience Internationale

Accréditation :--


 

Informations

 

CHAIRED BY:
Philip Hewitt, UK and Eurotox Registered Toxicologist, Global Head of Early Investigative Toxicology, Merck Healthcare KGaA
Stefan Przyborski, Professor of Cell Technology, Durham university
 
Over the past few years, 3D Cell Culture has gained momentum within the pharmaceutical industry due to the benefits that this model offers for in vitro applications patient-derived tissues, drug discovery, predictivity and validation, and safety and toxicity.
 
SMi’s 3D Cell Culture Conference will explore advances of organ and lab-on-a-chip, microphysiological systems, applications of technology and case studies, imaging, high throughput screening and advances in 3D cell culture models which make up core components within the 3D Cell Culture field.
 
Bioprinting has become increasingly efficient and accurate in building in vitro tissue models with the potential to provide pathologically relevant responses and model human disease mechanisms. Bio-printed structures yield phenotypic endpoints that are comparable with clinical studies and can provide a realistic prediction of clinical efficacy. The use of bioprinting is growing in big pharma companies as an alternative to organ-on-a-chip systems.
 
For the first time ever the NEW 3D Bioprinting Focus Day on 18 February 2020 will explore case studies from big pharma, biotech’s and academia exploring how bioprinting is being used in industry highlighting projects looking at stem cell therapy, drug screening and extracellular matrix scaffolds.
 
WHO SHOULD ATTEND?
Biotech / Pharma Companies - Team Leader, Junior Principle investigator, Cell and Molecular Scientist, Chief Scientific Officer, Deputy Director, Manager, Founder, CEO, Head, Director, Programme Manager, Lab Head, Toxicologist
Academia Professor - Cell Technology, Stem Cell Sciences, Biochemistry, Protein Technology and Tissue Engineering
Solution Providers – Manager, Head of, CEO, Director, Founder, Account Manager, President, CSO, Executive, Managing Director
 
Booking https://go.evvnt.com/520854-0?pid=4319
Tickets https://go.evvnt.com/520854-1?pid=4319
Brochure https://go.evvnt.com/520854-3?pid=4319
Inquiries https://go.evvnt.com/520854-4?pid=4319
Website https://go.evvnt.com/520854-5?pid=4319
Sponsor https://go.evvnt.com/520854-6?pid=4319
 
Prices:
Conference & Focus Day GBP 2398.00
Conference Only GBP 1499.00
Focus Day Only GBP 899.00
Promotional Literature Distribution at event GBP 999.00
Documentation - Conference Presentations GBP 499.00
 
Speakers: Petra Kerscher, Senior Scientist, Merck KGaA, Amna Magzoub, R&D Engineer, Novo Nordisk A/S Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Stefan Przyborski, Professor of Cell Technology, University of Durham, Philip Hewitt, UK and Eutrotox Registered Toxicologist, Head of Early Investigative Technology, Merck, Amna Magzoub, R&D Engineer, Novo Nordisk A/S, Lars Growth Grunnet, Senior Scientist, Novo Nordisk, Sarah Trenfi eld, Director of Innovation, FabRx Ltd, Hansjoerg Keller, Senior Investigator I, Musculoskeletal Disease Area, Novartis, Jason Ekert, Head Complex In Vitro Models, GSK, Petra Kerscher, Senior Scientist, Merck, Hansjoerg Keller, Senior Investigator I, Novartis, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University Gino Van Heeke, CSO, Engitix, Naheem Yaqub, PhD Candidate, University College London in Collaboration with GSK, Veronique Barban, Expert Virology, Research and Nonclinical Safety Department, Sanofi Pasteur, Floriane Groell, Senior Scientist, Novartis Pharma AG, Samuel Jackson, Programme Manager, Disease Models Efficacy and Safety Pharmacology, NC3Rs, Kenny Dalgarno, Professor of Manufacturing Engineering, Newcastle University, Maxime Feyeux, Co-Founder, President, CSO, TreeFrog Therapeutics, Michele Zagnoni, Reader, University of Strathclyde, Leonard Both, Senior Quality Assessor, Biologicals/Biotechnology Unit, MHRA, Wendy Rowan, Scientific Director, Novel Human Genetics Research Unit, GSK, Alexander D. Graham, Investigator Scientist, MRC Harwell Institute, Ellen J. Wehrens, Scientific Writer, Imaging Department, Princess Máxima Center for Pediatric Oncology, Rajesh Pandey, Postdoctoral Training Fellow, MRC Harwell Institute
 
Time: on Tuesday February 18, 2020 at 8:30 am (ends Thursday February 20, 2020 at 5:30 pm)
 

Lieu

Plan et itinéraire
Adresse de la conférence :
Copthorne Tara Hotel London Kensington
Scarsdale Place
W8 5SY London
Royaume-Uni
Plan et itinéraire

Renseignements

Pour accéder aux informations vous devez être connecté. Créer un compte est facile et gratuit!

Connexion à votre compte
S'inscrire sur Doctorama

Précisions

SMi's 4th Annual 3D Cell Culture Conference Médecine
--
Tout public
-- -- --
English

Divers

Pour plus d'informations sur SMi's 4th Annual 3D Cell Culture Conference, veuillez contacter SMi Group

Pour obtenir une lettre d'invitation, vous devez être connecté

Connexion à votre compte
S'inscrire sur Doctorama


Recommander cet évènement